Ibrutinib oral suspension bioavailability and compatibility for optimal enteral administration route

Jonas Paludo, Lisa Nodzon, Xavier Woot de Trixhe, Michelle Pacia, Heena Mavani, Harisha Atluri, Thomas J. Huemann, Jessica Shelly, Yemin Liu, Shayna Sarosiek

Open source

DOI
10.1177/20406207251399466
Published
2025-07
Container
Therapeutic Advances in Hematology
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/20406207251399466,
  title = {Ibrutinib oral suspension bioavailability and compatibility for optimal enteral administration route},
  author = {Jonas Paludo and Lisa Nodzon and Xavier Woot de Trixhe and Michelle Pacia and Heena Mavani and Harisha Atluri and Thomas J. Huemann and Jessica Shelly and Yemin Liu and Shayna Sarosiek},
  year = {2025},
  journal = {Therapeutic Advances in Hematology},
  doi = {10.1177/20406207251399466},
  url = {https://doi.org/10.1177/20406207251399466}
}

RIS

TY  - JOUR
TI  - Ibrutinib oral suspension bioavailability and compatibility for optimal enteral administration route
AU  - Jonas Paludo
AU  - Lisa Nodzon
AU  - Xavier Woot de Trixhe
AU  - Michelle Pacia
AU  - Heena Mavani
AU  - Harisha Atluri
AU  - Thomas J. Huemann
AU  - Jessica Shelly
AU  - Yemin Liu
AU  - Shayna Sarosiek
PY  - 2025
JO  - Therapeutic Advances in Hematology
DO  - 10.1177/20406207251399466
UR  - https://doi.org/10.1177/20406207251399466
ER  - 

APA

Paludo, J., Nodzon, L., Trixhe, X. W. D., Pacia, M., Mavani, H., Atluri, H., Huemann, T. J., Shelly, J., Liu, Y., & Sarosiek, S. (2025). Ibrutinib oral suspension bioavailability and compatibility for optimal enteral administration route. Therapeutic Advances in Hematology. https://doi.org/10.1177/20406207251399466

Source records